Navigation Links
ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Date:10/28/2009

and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains. ViroPharma commercializes Cinryze(TM) (C1 esterase inhibitor [human]) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package inserts at http://www.viropharma.com/Products.aspx). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile.

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Disclosure Notice

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events. Forward looking statements in this press release include our financial guidance for 2009, and statements regarding our clinical development programs, the effectiveness of our Vancocin and Cinryze sales efforts, our ability to continue to execute a successful launch of Cinryze, our ability to develop life cycle management plans for Cinryze, including designing and commencing clinical studies for additional indications, seeking rights to additional geographic territories and pursuing regulatory approvals in such territories.

We have opposed both the substance of the FDA's bioequivalence method and the manner in which it was developed. The FDA convened a meeting of its Advisory Committee for Pharmaceutical Science and
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
2. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
3. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
4. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
5. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
6. ViroPharma Announces Discontinuation of HCV-796 Development
7. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
8. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. ViroPharma to Present at the Natixis Bleichroeder Conference
10. ViroPharma to Present at Three Upcoming Healthcare Conferences
11. Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... and Chief Executive Officer, Doug Godshall , is ... Growth Conference at 8:30 a.m. EDT on Thursday, August ... 2015 at the InterContinental Boston. A live ...
(Date:8/4/2015)... Research and Markets ... the "MRI Systems Market to 2020 - ... Growth Driven by Developing Economies" report to ... 2020 - Focus on Patient Comfort and Operational ... the market, competitive landscape, and trends for three ...
(Date:8/4/2015)... 2015  Dr. Keesha Ewers of ... approval of flibanserin, or what is being touted ... of decreased female sexual desire back several decades. ... and addressing libido as a singular symptom with ... Photo - ...
Breaking Medicine Technology:HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2Global MRI Systems Market Outlook to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 3Potential FDA Approval of "Pink Viagra" Sends Wrong Message 4Potential FDA Approval of "Pink Viagra" Sends Wrong Message 5
... Vical Incorporated,(Nasdaq: VICL ) today announced ... independently produced video report featuring metastatic,melanoma patients treated ... is expected to be used,broadly by stations in ... Allovectin-7(R) trial, and in other cities by stations ...
... III Results Demonstrate Superior Reduction in In-Segment Late Loss, Non-Inferiority in ... ... V Compared to TAXUS, ABBOTT PARK, Ill., April ... Association (JAMA) demonstrated,that use of Abbott,s XIENCE(TM) V Everolimus Eluting Coronary ...
Cached Medicine Technology:Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 2Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 3Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 4Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report 5Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 2Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 3Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 4Study in JAMA Shows Patients Treated With Abbott's XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent 5
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... to Los Angeles commercial customers. Finding reliable hardware can be difficult and ... When putting an office together or designing a new facility, it is ...
(Date:8/4/2015)... ... , ... Angelina Jolie is in it at age 39. “It” is menopause, ... Angela DeRosa, DO, MBA, CPE aka “Dr. Hot Flash,” arguably the Southwest’s leading ... menopause. , Myth #1: Menopause only affects old ladies. – Menopause can affect ...
(Date:8/4/2015)... CA (PRWEB) , ... August 04, 2015 , ... ... General of the United States, Richard Carmona, M.D., M.P.H., FACS, to its Board ... medication errors and will save lives," Dr. Carmona said. "I strongly believe in ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... School is ... summer in the sun and preparing for the back-to-school scramble. Dublin, OH family ... is the best time for the annual dental checkup. In fact, the dentist recently ...
(Date:8/4/2015)... Thailand (PRWEB) , ... August 04, 2015 , ... ... United Kingdom and other international locations have shown a rise in binge drinking ... consistent link between binge drinking and depression, are continuing to examine trends and ...
Breaking Medicine News(10 mins):Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 2Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 3Health News:Ryadon, Inc. is Now Offering their Ball Bearing Drawer Slides to Los Angeles, CA Commercial Customers 4Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 2Health News:"Dr. Hot Flash" Debunks the Top 5 Menopause Myths 3Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 2Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 3Health News:Dublin OH Family Dentist Offers Complimentary Back-to-School Cleanings, a Revamped Suite, and In-House Esthetician to Accommodate All Patients 4Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3
... Plastic and Reconstructive Surgeon Kouros Azar, M.D. offers his ... Safety Awareness Week from March 8 to 14, 2009 sponsored ... safety and comfort are paramount to Dr. Azar , ... facilities located at 425 Haaland Drive, Suite 200 in Thousand ...
... of US citizens travel to Mexico for cancer treatment, ... is much less expensive, says TMD Unlimited, a medical ... Chronic Lymphocytic Leukemia (CLL), he went to three different ... In telling their story, the Teeters hope to help ...
... , , FRIDAY, March 13 (HealthDay News) -- Most kidney ... technique that eliminates the need for surgery, a pair ... findings have prompted the researchers to claim that the ... standard" of treatment for kidney cancer -- although not ...
... help women to take control of their health by ... Commission for Women and First Lady Judge Marjorie O. ... Wellness Guide kiosks in two Philadelphia-area Acme Markets. "Women ... themselves, and their own health ends up low on ...
... The human brain,s sensitivity to unexpected outcomes plays a ... behaviors, according to a new study by a team of ... a computer-based card game and microelectrodes to observe neuronal activity ... the journal Science , suggests that neurons in the ...
... the only Minnesota hospitals to receive designation ROCHESTER, Minn., ... Surgical Quality Improvement Program (ACS NSQIP) has recognized Mayo ... of the 26 ACS NSQIP participating hospitals in the ... patient care. As a participant in ACS NSQIP, Mayo ...
Cached Medicine News:Health News:Kouros Azar, M.D. (doctorazar.com), Noted Plastic and Reconstructive Surgeon, Offers Top 10 Tips to Patients to Help Celebrate National Patient Safety Awareness Week 2Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 2Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 3Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 4Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 5Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 6Health News:Medical Tourism - Choosing a Mexican Cancer Clinic 7Health News:Freezing Kidney Cancers Shows Promise 2Health News:Freezing Kidney Cancers Shows Promise 3Health News:PA Commission For Women Kiosk Helps Women Access Health Information 2Health News:University of Pennsylvania researchers find that the unexpected is a key to human learning 2Health News:American College of Surgeons Recognizes Mayo Hospitals for Exemplary Outcomes 2Health News:American College of Surgeons Recognizes Mayo Hospitals for Exemplary Outcomes 3
For the quantitative in vitro determination of Transferrin in human serum...
For the quantitative in vitro determination of Transferrin in Serum...
Determination of the Thrombin Time by STA Analyzers. Freeze-dried human thrombin (1.5NIH units/mL) with calcium....
Quantitative determination of Fibrinogen (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Medicine Products: